Immediate Impact
13 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Works of Yan Teng being referenced
Phase Ia study of CBP-1008, a bi-specific ligand drug conjugate targeting FRα and TRPV6, in patients with advanced solid tumors.
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yan Teng | 68 | 14 | 35 | 49 | 20 | 177 | |
| P André | 103 | 19 | 55 | 40 | 24 | 287 | |
| Nicole Natarelli | 81 | 7 | 15 | 55 | 21 | 200 | |
| Kirsi Isoherranen | 65 | 16 | 40 | 72 | 23 | 270 | |
| Monica Sharma | 62 | 10 | 26 | 44 | 18 | 296 | |
| Yaei Togawa | 95 | 25 | 50 | 21 | 22 | 217 | |
| Priya Patel | 25 | 13 | 23 | 97 | 19 | 272 | |
| Maria Chiara Sergi | 49 | 13 | 64 | 49 | 19 | 194 | |
| Pankaj Shukla | 52 | 8 | 21 | 30 | 25 | 269 | |
| E Rajesh | 27 | 31 | 25 | 77 | 27 | 250 | |
| J D Guin | 186 | 8 | 54 | 71 | 15 | 294 |
All Works
Login with ORCID to disown or claim papers
Loading papers...